Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Marcus & Millichap’s (NYSE:MMI) IPA Capital Markets Arranges USD 48.4M Refinance in Oklahoma

IPA Capital Markets, a division of Marcus & Millichap (NYSE:MMI), has facilitated 48.4M USD in financing to refinance the Britton Commerce Center, a Class-A industrial park located in Oklahoma City, Oklahoma. The transaction was executed on behalf of Gardner Tanenbaum, a real estate firm …

Team Kalkine | 12 November 2025

Analysts Lift Ratings and Price Targets on nVent Electric (NYSE:NVT)

Wall Street Zen upgraded shares ofnVent Electric (NYSE:NVT)from a “Buy” to a “Strong Buy” rating. The update was released in a research note issued on Saturday. This marks one of several recent analyst actions reflecting renewed coverage of the company.

Aditi Sarkar | 11 November 2025

Tencent Music’s (NYSE: TME) Q2 Profit Surges 37.5% Amid Higher Margins and Subscription Growth

Tencent Music Entertainment Group (NYSE:TME)operates as a holding company overseeing a portfolio of online music and audio entertainment platforms in China. Its main activities include delivering online music streaming, social entertainment functions, and associated value-added services to users across multiple digital ecosystems.

Aditi Sarkar | 11 November 2025

U.S. Market Sentiment Mixed Amid Tech Selloff and Progress Toward Ending Government Shutdown

Market Movers:On Monday, the top gainers were Galecto, Inc. (+248.48%), followed by Movano Inc. (+149.69%). On the contrary Katapult Holdings, Inc. (-34.45%), and Carbon Revolution Public Limited Company (-28.5%) declined the most the same day.

Team Kalkine | 11 November 2025

CleanSpark (NASDAQ:CLSK) Prices 1.15B USD Convertible Senior Notes with 27.5% Conversion Premium

CleanSpark, Inc. (NASDAQ:CLSK)announced the upsize and pricing of its 1.15B USD aggregate principal amount 0.00% Convertible Senior Notes due 2032. The offering is being conducted privately to qualified institutional buyers under Rule 144A of the Securities Act of 1933, as amended.

Team Kalkine | 11 November 2025

INOVIO (NASDAQ:INO) Files for Public Offering of Common Shares

INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company developing DNA medicines targeting HPV-related diseases, cancer, and infectious diseases, announced its plans to conduct a public offering of its common stock. All shares in the offering will be sold by the company, which will also grant …

Team Kalkine | 11 November 2025

Beyond Meat (NASDAQ:BYND) Reports Q3 Net Loss as U.S. Retail Demand Softens

Beyond Meat, Inc. (NASDAQ:BYND)announced results for the quarter ended September 27, 2025. Net revenues totaled 70.2M USD, down 13.3% from 81.0M USD in Q3 2024. The decline was primarily driven by a 10.3% decrease in product volume sold and a 3.5% drop in net …

Team Kalkine | 11 November 2025

TEN Holdings (NASDAQ:XHLD) Accelerates SaaS Growth with Ten Events Pro Early Adopter Launch

TEN Holdings, Inc. (NASDAQ:XHLD), via its subsidiary Ten Events, Inc., reported financial results for the quarter ended September 30, 2025. Revenue for Q3 2025 totaled 543,000 USD, a 1.5% increase from 535,000 USD in the same quarter of 2024. The growth was largely driven …

Team Kalkine | 11 November 2025

Workhorse Group (NASDAQ:WKHS) Q3 Results Highlight W56 Truck Sales

Workhorse Group, Inc. (NASDAQ:WKHS)reported results for the third quarter ending September 30, 2025. Net sales for Q3 2025 totaled 2.4M USD, slightly below 2.5M USD in Q3 2024, reflecting lower truck sales, partially offset by recognition of seven vehicles from deferred revenue. Cost of …

Team Kalkine | 11 November 2025

Precision BioSciences (Nasdaq:DTIL) Presents Phase 1 Data Showing Gene Editing in Humans

Precision BioSciences, Inc. (NASDAQ:DTIL)reported new findings from its ongoing Phase 1 ELIMINATE-B study of PBGENE-HBV at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2025. PBGENE-HBV is an in vivo gene editing therapy designed to target HBV cccDNA and …

Team Kalkine | 11 November 2025
Support

Hi! How can we help you today?

Loading…